PureTech Health PLC (PTCHF)
2.349
0.00 (0.00%)
USD |
OTCM |
Jun 28, 16:00
PureTech Health Enterprise Value: 306.81M for June 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 306.81M |
| June 27, 2024 | 306.81M |
| June 26, 2024 | 306.81M |
| June 25, 2024 | 364.01M |
| June 24, 2024 | 364.01M |
| June 21, 2024 | 366.71M |
| June 20, 2024 | 366.71M |
| June 18, 2024 | 382.96M |
| June 17, 2024 | 404.63M |
| June 14, 2024 | 420.33M |
| June 13, 2024 | 420.33M |
| June 12, 2024 | 449.31M |
| June 11, 2024 | 449.31M |
| June 10, 2024 | 418.17M |
| June 07, 2024 | 418.17M |
| June 06, 2024 | 468.54M |
| June 05, 2024 | 468.54M |
| June 04, 2024 | 468.54M |
| June 03, 2024 | 456.08M |
| May 31, 2024 | 456.08M |
| May 30, 2024 | 455.93M |
| May 29, 2024 | 455.93M |
| May 28, 2024 | 442.39M |
| May 24, 2024 | 445.10M |
| May 23, 2024 | 428.85M |
| Date | Value |
|---|---|
| May 22, 2024 | 442.39M |
| May 21, 2024 | 442.39M |
| May 20, 2024 | 449.16M |
| May 17, 2024 | 436.97M |
| May 16, 2024 | 401.78M |
| May 15, 2024 | 427.88M |
| May 14, 2024 | 400.84M |
| May 13, 2024 | 400.84M |
| May 10, 2024 | 417.06M |
| May 09, 2024 | 417.06M |
| May 08, 2024 | 414.36M |
| May 07, 2024 | 414.36M |
| May 06, 2024 | 414.36M |
| May 03, 2024 | 413.82M |
| May 02, 2024 | 400.84M |
| May 01, 2024 | 400.84M |
| April 30, 2024 | 400.84M |
| April 29, 2024 | 399.59M |
| April 26, 2024 | 399.59M |
| April 25, 2024 | 394.19M |
| April 24, 2024 | 383.39M |
| April 23, 2024 | 383.39M |
| April 22, 2024 | 375.29M |
| April 19, 2024 | 357.74M |
| April 18, 2024 | 421.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
70.43M
Minimum
Jun 17 2022
1.338B
Maximum
Mar 04 2021
615.08M
Average
572.62M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.058M |
| Palatin Technologies Inc | 21.45M |
| iBio Inc | 26.58M |
| Theriva Biologics Inc | -11.22M |
| Oragenics Inc | 4.308M |
Enterprise Value Related Metrics
| Earnings Yield | -10.22% |
| Normalized Earnings Yield | -23.42 |